Pompano Beach, FL, December 10, 2020 -- Rejuvel Bio-Sciences, Inc. (OTC Markets (NUUU) noticed an unwarranted increase in volume in their securities.
We urge the public to ignore rumors, postings or unauthorized news that does not originate directly from the company. This includes old items that may appear to some as new information.
In other developments, Rejuvel Bio-Sciences Director David Pollock has resigned from the Board of Directors.
Notice Regarding Forward-Looking Statements:
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone’s past success, either financial or strategic, is no guarantee of success. This news release speaks as of the date first set forth above and the Company assumes no responsibility to update the information included herein for events occurring after the date hereof.
Contact:
Media Manager
customercare@rejuvel.com